Healthcare provider profile · identity verified

Bilqees Fatima, M.D.

Family Practice · ANNISTON, AL · NPI 1588980593

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	291	61
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	219	36
Amlodipine Besylate	Amlodipine Besylate	217	77
Omeprazole	Omeprazole	216	71
Atorvastatin Calcium	Atorvastatin Calcium	212	63
Levothyroxine Sodium	Levothyroxine Sodium	162	42
Carvedilol	Carvedilol	137	45
Losartan Potassium	Losartan Potassium	130	43
Rosuvastatin Calcium	Rosuvastatin Calcium	127	46
Metformin Hcl	Metformin Hcl	112	35
Pantoprazole Sodium	Pantoprazole Sodium	111	49
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	108	49
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	108	17
Lisinopril	Lisinopril	107	28
Montelukast Sodium	Montelukast Sodium	105	35
Albuterol Sulfate Hfa	Albuterol Sulfate	99	39
Clonazepam	Clonazepam	81	12
Trazodone Hcl	Trazodone Hcl	79	23
Azithromycin	Azithromycin	74	57
Ozempic	Semaglutide	74	17
Fluticasone Propionate	Fluticasone Propionate	70	30
Potassium Chloride	Potassium Chloride	69	28
Tizanidine Hcl	Tizanidine Hcl	68	20
Duloxetine Hcl	Duloxetine Hcl	64	18
Methocarbamol	Methocarbamol	64	22
Allopurinol	Allopurinol	63	17
Hydrochlorothiazide	Hydrochlorothiazide	62	21
Furosemide	Furosemide	60	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	16
Famotidine	Famotidine	58	25
Clopidogrel	Clopidogrel Bisulfate	56	21
Sertraline Hcl	Sertraline Hcl	56	18
Celecoxib	Celecoxib	54	13
Jardiance	Empagliflozin	53	suppressed
Metoprolol Succinate	Metoprolol Succinate	51	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	16
Doxycycline Hyclate	Doxycycline Hyclate	49	36
Simvastatin	Simvastatin	48	13
Prednisone	Prednisone	47	32
Escitalopram Oxalate	Escitalopram Oxalate	46	15
Oxycodone Hcl	Oxycodone Hcl	46	suppressed
Tramadol Hcl	Tramadol Hcl	46	17
Metoprolol Tartrate	Metoprolol Tartrate	44	14
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Ezetimibe	Ezetimibe	43	11
Eliquis	Apixaban	41	suppressed
Mirtazapine	Mirtazapine	41	14
Alprazolam	Alprazolam	40	suppressed
Meloxicam	Meloxicam	39	11
Hydralazine Hcl	Hydralazine Hcl	38	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Lovastatin	Lovastatin	36	suppressed
Memantine Hcl	Memantine Hcl	36	14
Cefdinir	Cefdinir	35	30
Ibuprofen	Ibuprofen	35	11
Bupropion Hcl Sr	Bupropion Hcl	34	suppressed
Farxiga	Dapagliflozin Propanediol	32	suppressed
Meclizine Hcl	Meclizine Hcl	31	11
Pregabalin	Pregabalin	30	suppressed
Fluconazole	Fluconazole	29	16
Pravastatin Sodium	Pravastatin Sodium	29	11
Tamsulosin Hcl	Tamsulosin Hcl	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	27
Ondansetron Hcl	Ondansetron Hcl	28	20
Raloxifene Hcl	Raloxifene Hcl	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	27	suppressed
Glimepiride	Glimepiride	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Sucralfate	Sucralfate	25	12
Dicyclomine Hcl	Dicyclomine Hcl	24	11
Clonidine Hcl	Clonidine Hcl	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Mounjaro	Tirzepatide	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Etodolac	Etodolac	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Rizatriptan	Rizatriptan Benzoate	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	17	13
Bupropion Xl	Bupropion Hcl	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Varenicline Tartrate	Varenicline Tartrate	17	suppressed
Cephalexin	Cephalexin	16	12
Nifedipine Er	Nifedipine	16	suppressed
Edarbi	Azilsartan Medoxomil	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	11
Vascepa	Icosapent Ethyl	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Atenolol	Atenolol	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Glipizide Er	Glipizide	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	12
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Baclofen	Baclofen	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	11
Easy Touch Pen Needle	Pen Needle, Diabetic	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Linzess	Linaclotide	12	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Sotalol	Sotalol Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Temazepam	Temazepam	12	suppressed
Torsemide	Torsemide	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Estradiol	Estradiol	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error